News Focus
News Focus
icon url

tangerine

07/17/12 11:11 PM

#21703 RE: richme #21699

So what is your answer?

The first three seem like the most popular guesses, we have an I don't care too. Weird answer there!

You never answered - Which will be the first product announced for the BE trials and 5052b studies?

Oxycodone
Hydromorphone
Morphine
Percodin
Percocet
Oxymorphone
?????

So many possibilities

Funding to be announced soon too..


so we have (besides the current 4 commercial products)

5 products pending FDA approval
4 products in scaleup
Return of Lodrane
HITKs generic of a 100m branded product
MIK001 with Actavis/Mikah
HK deal

Completion of second mfg facility - currently requires FDA approval


Plus Additional products etc....

CEO - "My vision is to create a line of abuse resistant opioid products using our patented technology. Push comes to shove, that's where the value -- the true large value of the Company is, is in the creation of that line of abuse resistant products. Nobody in management is working to see this Company grow by million-dollar increments.

We are going for the doubles, the triples, and the home runs. And we think we can do that.

If you look at the abuse resistant market and you look at some of the problems that other companies have had in manufacturing their products on a consistent basis, we think one of the big advantages that we have is that we have a system that can be consistently manufactured over and over again with many different products."